<DOC>
	<DOC>NCT00648141</DOC>
	<brief_summary>To compare the safety and efficacy of once-daily and twice-daily celecoxib versus diclofenac for the treatment of ankylosing spondylitis</brief_summary>
	<brief_title>Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis, Ankylosing</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Diagnosis of ankylosing spondylitis defined according to modified New York criteria, and with axial involvement Requiring daily treatment with nonsteroidal antiinflammatory drugs during the previous 30 days Patients with inflammatory enterophathy, and with extraarticular manifestations Patients with known vertebral compression Received corticosteroids 6 weeks prior to the baseline visit; patients on stable dose of prednisolone equivalents â‰¤ 10 mg/ day for at least 14 days before randomization were permitted</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>